Our results underline the role of Tregs in the progression of CLL and more importantly suggest that reactivation of the existing, exhausted T cell populations with anti-PD-L1 therapy, might be insufficient to block the disease progression. Here, CD274 is linked to B-cell chronic lymphocytic leukemia.